Dr. Torres Cabala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-3151
Summary
- Dr. Carlos Torres Cabala is a pathologist in Houston, TX and is affiliated with University of Texas M.D. Anderson Cancer Center. He received his medical degree from National University of San Agustin of Arequipa- Faculty of Medicine and has been in practice 23 years. He specializes in dermatopathology and anatomic pathology.
Education & Training
- University of Texas M D Anderson Cancer CenterFellowship, Dermatopathology, 2007 - 2008
- National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2004 - 2007
- National Cancer InstitutePost-Doctoral Fellowship, 2001 - 2004
- Universidad Peruana Cayetano HerediaResidency, Anatomic Pathology and Clinical Pathology, 1996 - 2000
- Universidad Nacional de San AgustinMS candidate, Biochemistry and Molecular Biology, 1994 - 1996
- National University of St. Augustin of Arequipa - Faculty of MedicineClass of 1994
Certifications & Licensure
- TX State Medical License 2008 - 2025
- VA State Medical License 2006 - 2020
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Dermatopathology
Publications & Presentations
PubMed
- 107 citationsGranulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patientsMichael T. Tetzlaff, Kelly C. Nelson, Adi Diab, Gregg A Staerkel, Priyadharsini Nagarajan
Journal for Immunotherapy of Cancer. 2018-02-12 - 104 citationsAutoimmune dermatologic toxicities from immune checkpoint blockade with anti-PD-1 antibody therapy: a report on bullous skin eruptionsGeorge Jour, Isabella C. Glitza, Rachel M. Ellis, Carlos A. Torres-Cabala, Michael T. Tetzlaff
Journal of Cutaneous Pathology. 2016-08-01 - 31 citationsSuprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-li...Wei Shen Chen, Michael T. Tetzlaff, Hafeez Diwan, Richard R. Jahan-Tigh, Adi Diab
Journal of Cutaneous Pathology. 2018-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: